PA
NEO icon

Pineridge Advisors’s NeoGenomics NEO Stock Holding History

Pineridge Advisors’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29
Closed -$478 – 617
2024
Q4 		$478 Hold
29
– – ﹤0.01% 574
2024
Q3 		$428 Hold
29
– – ﹤0.01% 542
2024
Q2 		$402 Hold
29
– – ﹤0.01% 579
2024
Q1 		$456 Sell
29
-304
-91% -$4.69K ﹤0.01% 561
2023
Q4 		$5.39K Buy
+333
New +$5.45K ﹤0.01% 475

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Pineridge Advisors's NEO Position: Q1 2025 in Review

Pineridge Advisors sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 29 shares — an estimated $478 sold.

Pineridge Advisors first reported a position in NEO in Q4 2023 and held it in 5 quarters. The position peaked at $5.39K in Q4 2023. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

  • Pineridge Advisors reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
  • Pineridge Advisors sold 29 NeoGenomics shares in Q1 2025, an estimated $478.
  • Pineridge Advisors first reported a position in NeoGenomics in Q4 2023 and held it in 5 quarters.
  • Pineridge Advisors's NeoGenomics position peaked at $5.39K in Q4 2023.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Pineridge Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.